Taejon, South Korea

Jae-Hong Lim

This inventor holds 3 USPTO granted patents. Top assignee: Lg Life Sciences, Limited. Active years: 2007-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jae-Hong Lim. Retrieved from https://idiyas.com/inventor/jae-hong-lim-352tf3jm

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 15.0

ph-index = 2

Forward Citations = 6(Granted Patents)


Location History:

  • Yuseong-gu, KR (2007)
  • Taejeon, KR (2009 - 2010)

Company Filing History:


Years Active: 2007-2010

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Mind of Jae-Hong Lim

Introduction

Jae-Hong Lim, hailing from Taejeon, South Korea, is an accomplished inventor known for his significant contributions in the field of pharmaceuticals. With a total of three patents to his name, Lim is particularly noted for his work on acyclic nucleoside phosphonate derivatives, which have crucial implications for antiviral therapies.

Latest Patents

Among his latest patents, Lim’s work on "Acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same" stands out. This invention relates to a novel acyclic nucleoside phosphonate derivative that serves as an antiviral agent, especially effective against the hepatitis B virus. The patent describes a comprehensive process for preparing these compounds, which may include various stereoisomers, salts, and functional groups that enhance their therapeutic efficacy.

Career Highlights

Jae-Hong Lim is a prominent figure at LG Life Sciences, Limited, where he continues to innovate in the realm of medicinal chemistry. His research has been pivotal in addressing viral infections, and his patents demonstrate a commitment to enhancing public health through scientific advancement.

Collaborations

Collaboration is key to Lim's success, and he has worked alongside esteemed coworkers Jong-Ryoo Choi and Jeong-Min Kim. Their joint efforts in the laboratory have led to groundbreaking research and the successful development of patents that promise to transform treatment options for viral diseases.

Conclusion

Jae-Hong Lim exemplifies the spirit of innovation and dedication to improving health outcomes through research. His patented inventions not only showcase his expertise but also hold the potential for significant advancements in antiviral therapies. As he continues to push the boundaries of science, Lim’s work will undoubtedly leave a lasting impact on the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…